You have successfully logged out.

Hello !
Logout

B. Braun's Complete OPAT Pathway

Supporting Outpatient Parenteral Antimicrobial Therapy

Patient Access. Intravenous Drug Preparation. Administration.

 

OPAT facilitates early discharge or admission avoidance of medically stable patients requiring intravenous (IV) antimicrobial therapy. OPAT is clinically and cost effective for a range of infections and allows optimisation of hospital bed capacity and patient flow. 1

Collaborating through our partners

B. Braun’s OPAT product pathway benefits both

healthcare services and the patient by reducing

impatient stay, easing bed pressures and maximizing

quality of life

Settings standards together. Empowering practitioners. Shaping the future

Discover our highlight products

Our Services

Sharing expertise with health care professionals

Contact Us

Please complete the form below to get in touch with our OPAT Pathway team.

Your details

Email communication

B. Braun Medical Ltd would like to send you product information and updates including new launches, education, patient stories and events. You may occasionally receive email marketing communications from other parts of the B. Braun business which are of relevance to you.

check_circle

Your request could not be submitted. Please try again.

warning

References

  1. Based on HSCIC Hospital Episode Statistics April 2014-March 2015 Admitted Patient Care FCEs excluding day cases
  2. Chapman A 2013 Outpatient Parenteral Antimicrobial Therapy in a Changing NHS Challenges and Opportunities (upto 4% of hospital admissions solely for IV antimicrobials)
  3. Chapman et Al 2009 Clinical Efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT) a UK perspective (mean duration of therapy 22.5 days)
  4. Lord Carter 2-16 Operational productivity and performance in English NHS acute hospitals page 66 (estimated cost of hospital bed day £300)
  5. https://www.gov.uk/government/publications/health-matters-antimicrobial-resistance/health-matters-antimicrobial-resistance
  6. Corwin, P/, Toop, L, McGeoch, G., Than, M., Wynn-Thomas, S., Wells, J., Dawson, R., Abernethy, P., Pithie, A., Chambers, S., Fletcher, L and Richards